Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemiaBo Yu, Natarajan Muthusamy|Blood|2012Cited by 64
FTY720 Shows Promising <i>In vitro</i> and <i>In vivo</i> Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell LymphomaQing Liu, Natarajan Muthusamy|Clinical Cancer Research|2010Cited by 52
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphomaAnuvrat Sircar, Lalit Sehgal, Zijun Y. Xu‐Monette et al.|Leukemia|2023Cited by 13